Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora

Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile -Associated Diarrhea and Prevention of Disease Recurrence in Hamsters Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004 Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coli Antianaerobic Activity of Sulopenem Compared to Six Other Agents In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria